Sabin Institute Scientist Receives Tropical Medicine Medal

PHILADELPHIA, PA, December 3, 2003—Hartford, Connecticut native Peter J. Hotez, MD, PhD, FAAP claimed the 2003 Bailey K. Ashford Medal here today at the centenary meeting of the American Society of Tropical Medicine and Hygiene. Hotez is chairman of Microbiology and Tropical Medicine, The George Washington University, and senior fellow of the Albert Sabin Vaccine Institute, headquartered in New Canaan, Connecticut.

Sabin

Sabin Vaccine Institute Concludes 2nd Meeting of the Cancer Vaccine Consortium

NEW CANAAN, CT, November 4, 2003—The Sabin Vaccine Institute, a non-profit research and education organization based in New Canaan, today concluded the second meeting of the Cancer Vaccine Consortium (CVC). The three-day meeting was held in Bethesda, Maryland and drew attendees from the United States, Canada and Europe. The purpose of the CVC is to enhance collaboration among companies undertaking research and development on cancer immunotherapies.

Sabin

Sabin Vaccine Institute Appoints Executive Director, Cancer Vaccine Consortium

NEW CANAAN, CT, October 27, 2003—The Sabin Vaccine Institute announced the appointment of Nathan Tinker, PhD, as executive director of the Cancer Vaccine Consortium (CVC), a new initiative of the decade- old New Canaan-based non-profit organization. Dr. Tinker, a resident of Norwalk, will be the principal organizer of the Consortium program, which works with a growing list of biopharmaceutical companies to advance discovery of new therapies for a range of cancers. Dr.

Sabin

Immunotherapies for Cancer Are Focus of Newly Formed Consortium

NEW CANAAN, CT—Treatment options for a variety of cancers are expanding to include an array of exciting new approaches. Along with well-established companies, newer biotechnology and biopharmaceutical firms are looking to break into an emerging market that would provide vaccines for both solid cancers—such as melanoma, prostate, breast, lung, cervical, colon, brain, and ovarian—and blood borne cancers—such as lymphoma, leukemia, and myeloma.

Sabin

Sabin Vaccine Institute to Honor Pharmaceutical Executive, CHF Founders and University President at New York City Benefit Dinner

NEW CANAAN, CT—The Sabin Vaccine Institute presents its highest non-science awards on May 14 to four illustrious groundbreakers in business, social service, and academia. One is the leader of one of the world’s premier pharmaceutical companies, two are collaborators in starting an organization to benefit the nation’s medically underserved children, and a fourth is a prominent university president.

gwu.edu

Accelerating Cancer Vaccine Development is Rallying Cry at 2003 Colloquium on Cancer Vaccines and Immunotherapy

NEW CANAAN, CT— Cancer vaccines present an elusive goal, yet one that is increasingly within reach for biomedical researchers. Their hope is to offer physicians and cancer patients more and better therapy options than radiation and chemotherapy.

Sabin

Sabin Vaccine Institute Taps Ciro A. de Quadros, MD, MPH for International Programs Post

NEW CANAAN, CT—The Sabin Vaccine Institute has named disease eradication champion Ciro A. de Quadros, MD, MPH to lead its international programs. Dr. de Quadros is a distinguished international public health diplomat, having this year completed an eight-year term as director of the Division of Vaccines and Immunization for the Pan American Health Organization (PAHO). Dr.

Sabin

Pages